NSEReply to Clarification- Financial results25 Jun 2026 · 25 Jun 2026, 05:55 pm
Reply to Clarification- Financial results
Gujarat Themis Biosyn Limited · GUJTHEM
✦ AI SummaryResults
Gujarat Themis Biosyn Limited clarifies the omission of Earnings Per Share (EPS) in their XBRL filing for the quarter ended 31-Mar-2026, stating it was an inadvertent technical error with no impact on financial performance or profitability.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
The Exchange had sought clarification from Gujarat Themis Biosyn Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Attachments (1)
📄pdf
Download →
GUJARATTHEMIS_20062026155639_Clarification_to_NSE_EPS_query.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TE: 0260-2430027 / 2400639
E-mail:hrm@gtbl.in.net
20th June, 2026
The Listing Department
National Stock Exchange of India
Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra (East), Mumbai- 400051
Symbol: GUJTHEM
Dear Sir / Madam,
Sub: Subject: Clarification regarding discrepancy in XBRL filing of Financial Results –
EPS not mentioned
With reference to your communication regarding the Financial Results XBRL submitted on May 25,
2026, wherein it has been observed that Earnings Per Share (EPS) was not mentioned in the XBRL
filing, we wish to submit the following clarification:
Due to an inadvertent omission while filing the financial results in XBRL format, the EPS disclosure
was not captured in the XBRL submission. However, there is no change in the financial results
approved by the Board of Directors and submitted to the Exchange. The omission is purely technical
in nature and does not impact the financial performance, profitability, or any other financial
information disclosed by the Company.
We have taken note of the observation and are submitting the revised/corrected XBRL filing
incorporating the EPS details as required.
We request you to kindly take the above clarification on record and oblige.
Thanking you.
Yours faithfully,
Kindly take the above on record.
For GUJARAT THEMIS BIOSYN LIMITED
Vineet Gawankar
Company Secretary & Compliance Officer
MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104
Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019 E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in